Stunner Biologics Characterization

Importance of the Topic

Protein characterization underpins biotherapeutic development, quality control and formulation studies. Integrating concentration measurement with size and aggregation analysis on minute sample volumes accelerates decision making and conserves precious material. The ability to obtain high-confidence data on protein purity, stability and interactions in a single workflow addresses critical industry and research needs.

Objectives and Study Overview

This work presents a unified platform that combines UV/Vis spectroscopy and dynamic light scattering (DLS) to deliver concentration, size distribution, polydispersity and aggregation metrics from a 2 µL protein sample. Key aims include evaluating accuracy and precision of protein quantification, assessing DLS-derived size and aggregate detection performance, and demonstrating biophysical parameter determination (B22, kD) and conjugate characterization.

Instrumentation

• Microfluidic plate with dual optical pathlengths (0.1 mm and 0.7 mm) covering 0.03–275 OD (10 mm equivalent).
• Xenon flash lamp–based UV/Vis spectrophotometer, spectral range 230–750 nm, resolution <2 nm, absorbance precision <0.01 OD.
• Dynamic light scattering module with two 660 nm laser diodes, avalanche photodiode detector, hydrodynamic diameter range 0.3–1000 nm, size accuracy ±2%.
• Capability for standard DLS and rotating-angle DLS (5–30 angles) for high-resolution size profiles.

Key Results and Discussion

Quantification tests using an IgG dilution series showed linearity (R2 = 0.9999), precision <1% CV and accuracy within 2% across 2–250 mg/mL. DLS measurements resolved monomeric ovalbumin (6.6 nm, PDI 0.09) and thyroglobulin (22 nm, PDI 0.12) with tight replicate overlap. Aggregate detection distinguished samples with 1% high-molecular-weight species based on mass and intensity distributions. Self-interaction parameters B22 and diffusion interaction coefficient kD were determined for IgG in different buffers by simple dilution series. Conjugate characterization of antibody-drug and antibody-oligo constructs yielded drug-to-antibody ratio (DAR 4.3) and oligo loading metrics in one integrated UV/Vis and DLS assay.

Benefits and Practical Applications

• Minimal sample consumption (2 µL) reduces reagent costs and preserves valuable analyte.
• High throughput: 96 UV/Vis readings in ~10 minutes; full concentration plus DLS in ~1 hour.
• Automatable workflow for large screens or routine QC operations.
• Comprehensive data (concentration, size, aggregation, interactions, conjugate ratios) in a single run.

Future Trends and Opportunities

Advancements may include multi-angle and multi-wavelength scattering for deeper structural insights, real-time monitoring of protein stability under variable conditions, integration with machine learning for predictive formulation screening, and extension to emerging modalities such as nanoparticles and virus-like particles.

Conclusion

The described platform unifies UV/Vis quantification and fit-for-purpose DLS to deliver robust, high-throughput protein characterization from microliter samples. Its accuracy, precision and broad applicability make it a powerful tool for biopharma R&D, QC and formulation development, streamlining workflows and enhancing data quality.

Reference

No external literature references were provided in the source document.